Amanta Healthcare Limited
Bookbuilding IPO · NSE, BSE
- Price band
- ₹120 - ₹126
- Lot size
- 119 shares
- Issue amount
- ₹126 cr
- Total subscription
- 82.61×
- Opens
- 1 Sept 2025
- Closes
- 3 Sept 2025
- Allotment
- 4 Sept 2025
- Listing
- 9 Sept 2025
Offer at a glance
Issue overview
- Issue size
- 1,00,00,000 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹14,280
- Fresh issue
- ₹126 cr
- Offer for sale
- ₹0 cr
- Registrar
- Link Intime India Private Limited
- Listing exchange
- NSE, BSE
- Maximum investment
- ₹14,994
- Issue type
- Bookbuilding IPO
- Shares before issue
- 2,88,29,351
- Shares after issue
- 4,13,29,351
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail | 1 | 119 | ₹14,994 |
| sHNI | 14 | 1,666 | ₹2,09,916 |
| bHNI | 67 | 7,973 | ₹10,04,598 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| RETAIL | 29,412 | 13,29,970 |
| HNIs(10L +) | 600 | 27,311 |
| HNIs (2-10L) | 300 | 50,755 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 25.2 | 903.7 |
| FIIs | 0 | 255.41 |
| FIs | 0 | 242.56 |
| Mutual Funds | 0 | 30.2 |
| Others | 0 | 375.53 |
| RETAIL | 44.1 | 2,424.53 |
| HNIs 2+ | 6.3 | 1,108.9 |
| HNIs 10+ | 12.6 | 2,849.2 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| EPS | 0 | 0 | 0 |
| ROE | 12.42 | 5.27 | -3.27 |
| ROCE | 13.72 | 12.76 | 12.19 |
| RONW | 0 | 0 | 0 |
| PRE IPO(PE) | 34.59 | 0 | 0 |
| POST IPO(PE) | 46.59 | 0 | 0 |
Values and labels as reported in the issue data.
Peer comparison
| Company | P/E(X) | CMP* (₹) | Face value (₹) | NAV/Share (₹) | RONW(%) | EPS (Basic) (₹) |
|---|---|---|---|---|---|---|
| Denis Chem Lab Limited | 15.92 | 92.65 | 10.00 | 61.33 | 9.49 | 5.82 |
| Amanta Healthcare Limited | NA | NA | 10.00 | 33.43 | 10.89 | 3.71 |
Company information
Company profile
Amanta Healthcare Limited, founded in December 1994, is a pharmaceutical company engaged in developing, manufacturing, and marketing sterile liquid products, mainly parenteral formulations, using advanced Aseptic Blow-Fill-Seal and Injection Stretch Blow Moulding technologies. The company also produces medical devices and offers a wide range of products including IV fluids, diluents, ophthalmic solutions, respiratory care products, irrigation solutions, first-aid items, and eye lubricants. Its business is divided into three units: national sales, international sales, and product partnerships with Indian and global pharmaceutical companies. Amanta manufactures over 45 generic products, distributed across India through 320 distributors and stockists, while also exporting to Africa, Latin America, the UK, and other regions. Its products are registered in 19 countries, and in Fiscal 2025, it exported branded products to 21 countries. As of March 31, 2025, the company employed 1,718 people across its formulation, development, and quality laboratories.
Strengths
- Increasing Healthcare Access: greater reach of medicines and insurance fueling pharma demand
- Policy Support: government schemes, tax incentives, and subsidies driving sector growth
- Strong Talent Base: vast pool of scientists and researchers enhancing pharma capabilities
Risk factors
- Single Facility Dependence: reliance on one Gujarat unit makes operations vulnerable to power issues, accidents, or disasters
- Production & Quality Concerns: delays or defects may cause cancellations and client loss
- Litigation Challenges: ongoing cases could harm business, finances, and growth plans
Promoters
Bhavesh Patel
Vishal Patel
Jayshreeben Patel
Jitendra Kumar Patel
Milcent Appliances Private Limited
Registrar & documents
Lead manager
Beeline Capital Advisors Private Limited
Registrar & contacts
Link Intime India Private Limited
[email protected]Official registrar portal ↗Check allotment status on registrar →Registered office
8th Floor, Shaligram Corporates C.J. Marg Ambli, Ahmedabad, Gujarat, 380058
079 67777600
[email protected]Company website ↗Frequently Asked Questions
What is Amanta Healthcare IPO GMP today?
As of today, Amanta Healthcare IPO Grey Market Premium (GMP) is reported at +₹9 per share. Based on the upper price band of ₹126, the estimated listing price is ₹135 (+7.1% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.
What is the lot size and minimum investment for Amanta Healthcare IPO?
The minimum bid lot size for Amanta Healthcare IPO is 119 shares. At the cut-off price of ₹126 per share, retail investors need a minimum application amount of ₹14,994 per lot. Retail applicants can apply for a maximum of 13 lots (up to ₹2,00,000).
When will Amanta Healthcare IPO allotment status be announced?
The allotment status for Amanta Healthcare IPO is scheduled to be finalized on 4 Sept 2025. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Link Intime India Private Limited's official portal or via BSE/NSE allotment portals.
How can I check Amanta Healthcare IPO allotment status online by PAN?
To check Amanta Healthcare IPO allotment status: 1) Visit the registrar portal (Link Intime India Private Limited) or the BSE IPO allotment page. 2) Select 'Amanta Healthcare Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.
Explore More IPO Analysis & Live Tools
Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.